Health

The Menopause Society to Launch NextGen Now Initiative to Transform Menopause Training
The Ad Council, Huntsman Mental Health Foundation and Amazon Announce "The Mind Set" to Support Mental Health
Mycovia Pharmaceuticals, Inc. Announces First Participant Enrolled in an Investigator-Initiated Phase 2 Study for Cryptococcal Meningitis
ScriptSave RxCheck® Simplifies How Pharmacies Compare Discount Programs, Saving Stores and Customers Time and Money
ImageTrend Delivers Ontario-Compliant Dataset to Support EMS Compliance with Provincial Standards
Workforce Pressures Mount for Nurses and Technicians as AI and Politics Enter the Workplace: New Report
New Wellness App BlissTrax Launches to Revolutionize Stress Management
NYU Langone Perlmutter Cancer Center Names Renowned Liver Cancer Researcher to Lead Its Liver Cancer Program
Budr Cannabis Strengthens Connecticut Footprint with New Acquisitions
The American Diabetes Association and The Leapfrog Group Honor 36 Hospitals for Exceptional Inpatient Care
Repertoire Immune Medicines Appoints Robert Andtbacka, MD, CM, FACS, FRCSC, as Chief Medical Officer and Advances TCR Bispecific Development Candidate Toward the Clinic
Avant Technologies and Partner, Ainnova, Finalizing Automated Retinal Camera Prototype Ahead of Full-Scale Development
Oracle Enables Automation of Drug Supply Management Across Vendors and Studies to Help Speed and Simplify Clinical Trials
MINITA SHAH-MARA JOINS BLUE CROSS BLUE SHIELD OF MASSACHUSETTS AS CHIEF PEOPLE OFFICER
Continuity Biosciences übernimmt Focal Medical, um die gezielte Wirkstoffabgabe bei Bauchspeicheldrüsenkrebs voranzutreiben
Continuity Biosciences adquiere Focal Medical para avanzar en la administración dirigida de fármacos
nimble solutions Acquires Contego to Expand Payer Guidance for Providers
Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S.
Vasa Therapeutics Announces Successful Completion of First-in-Human Study for Investigational Therapy VS-041, a Small Molecule Drug Candidate for Heart Failure with Preserved Ejection Fracture
DRUID AI receives Microsoft certification for AI in Healthcare